Summary
QED Therapeutics Inc
Founded in 2018
Description
Learn how QED Therapeutics is advancing the fight against cholangiocarcinoma and other FGFR-driven diseases through research and innovation.
Strengths
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since QED Therapeutics Inc was founded, the company has grown faster than the industry average
Weaknesses
- QED Therapeutics Inc has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
QED Therapeutics Inc's annual revenue
$3874000
Based on Kona Equity data
-
Revenue per employee
$176090
-
Variance of revenue growth
0.09
-
Annual revenue growth since founding
$645667
-
Revenue growth rate from first known quarter to current
-9.5%
Employee Count
22 employees
-
Employee growth rate from first known quarter to current
-4.8%
Executives
Keith Steward
Vice President, Medical Affairs
k**@qedtx.comKimberly Richards
Associate Director, Quality Assurance
k**@qedtx.comFarah Khan
Clinical Trial Associate
f**@qedtx.comShugufa Afifi
CTM, Clinical Operations
s**@qedtx.comElizabeth Freas
Senior Manager, Clinical Trial
e**@qedtx.comXue Ge
Vice President, Clinical Pharmacology and PKDM
x**@qedtx.comElizabeth Woodling
Senior VP, Quality Assurance
e**@qedtx.comRoo Vold
Senior Vice President Global Pharmacovigilance
r**@qedtx.comMehrak Kiankarimi
Vice President, Program Management
m**@qedtx.comElena Muslimova
Associate Medical Director
e**@qedtx.comXue Snow
Vice President, Clinical Pharmacology
x**@qedtx.comDeborah Mortensen
Director, Medical Writing
d**@qedtx.comBrian Boyles
Senior Manager, Quality Assurance
b**@qedtx.comScott Collins
Senior Vice President - Market Access
s**@qedtx.comMarc Lesnick
Senior VP, Regulatory Affairs
m**@qedtx.comEdward Oliva
Senior Clinical Program Manager
e**@qedtx.comJack Winnike
Director, Regulatory Affairs
j**@qedtx.comAndrea Orozco
Senior Office Administrator
a**@qedtx.comHiywot Takkele
Director, Clinical Operations
h**@qedtx.comTodd Bobick
Director, Clinical Quality Assurance
t**@qedtx.comVanessa Solis
Senior Executive Administrator To Chief Marketing Officer
v**@qedtx.comMeenakshi Srivastava
Medical Writer
m**@qedtx.comTerry Cho
Senior Director, Clinical Operations
t**@qedtx.comMichael Leblanc
Director, Analytical Development
m**@qedtx.comRick Panicucci
Senior Vice President, CMC
r**@qedtx.comRoshni Khanna
Lead Generation Executive
r**@qedtx.comDawn Hill
Senior VP, Clinical Operations
d**@qedtx.comSudesh Kamath
Senior Director, CMC Head of Regulatory Affairs
s**@qedtx.comHelen Wei
Senior Director, Biostatistics
h**@qedtx.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
6.85 M
-
Page views per visitor
1.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Inspyr Therapeutics
inspyrtherapeutics.com- Founded in 2003
- Location: Westlake Village, CA
- Annual Revenue: $212.0K
- Employees: 1
Testicular Cancer
weillcornellgucancer.org- Location: New York, NY
- Annual Revenue: $2.5M
- Employees: 19
- Weill Cornell GU Cancer is a program that focuses on the study, diagnosis, and treatment of genitourinary (GU) malignancies. They share new and innovative findings in the field of GU oncology through their blog and participate in conferences and sympos...
PaCMEN
pacmen.org- Location: Rockville, MD
- Annual Revenue: $2.3M
- Employees: 6
- PaCMEN is a consortium created to conduct translational studies aimed at improving the treatment of pancreatic cancer.
Organoid Research Group
organoidresearch.com- Founded in 2018
- Location: Cambridge, MA
- Annual Revenue: $2.0M
- Employees: 9
- The Organoid Research Group is an online resource for scientists with an interest in oncology drug development. The OrganoidResearch.com website provides access to current news, events, and publications, and serves as a platform to exchange knowledge a...
ArQule , Inc.
arqule.com- Founded in 1993
- Location: Burlington, MA
- Annual Revenue: $2.4M
- Employees: 34
- ArQule, Inc. is a clinical stage biotechnology company engaged in the research and development of cancer therapeutics. The Company is focused on developing small molecule drugs that target specific biological pathways implicated in various cancers and ...
Auron Therapeutics
aurontx.com- Founded in 2018
- Location: Newton, MA
- Annual Revenue: $934.0K
- Employees: 6
- Auron Therapeutics is a biotechnology research company that aims to cure cancer by transforming malignant cells into more normal functioning cells. They have developed a proprietary database of single cell genomic data and an AI-powered computational p...
Key Information
- Name: QED Therapeutics Inc
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 3254; 32
See similar companies
-
By City San Francisco Small Biotechnology Company in San Francisco Mid-size Biotechnology Company in San Francisco Biotechnology in San Francisco Small Biotechnology in San Francisco Mid-size Biotechnology in San Francisco
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 3 Founded in 2018 SIC: 80 SIC: 283 NAICS: 3254 NAICS: 32 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
QED Therapeutics Inc's headquarters are located at 75 Federal St. San Francisco, CA 94107.
QED Therapeutics Inc's official website is qedtx.com
QED Therapeutics Inc's annual revenue is $3.9 M.
QED Therapeutics Inc's SIC: 80; 283
QED Therapeutics Inc's NAICS: 3254; 32.
QED Therapeutics Inc has 22 employees
QED Therapeutics Inc is in the industry of Biotechnology.
